HOXB13 alters chromatin accessibility in prostate cancer through interactions with the SWI/SNF complex
Lingadahalli, S.; Fazlioglu, B. E.; Altintas, U. B.; Cingoz, A.; Tekoglu, E.; Yu, I. P. L.; Andomat, H.; Kulac, I.; Morova, T.; Xiao, K.; Dikbas, U. M.; Gleave, M.; Fazli, L.; Cejas, P.; Long, H.; Cherkasov, A.; Zwart, W.; Collins, C.; Bagci-Onder, T.; Lack, N. A.
Show abstract
HOXB13 is a posterior homeobox protein that is associated with the initiation and growth of prostate cancer (PCa). While most research has focused on the role of HOXB13 on androgen receptor (AR) activity, we demonstrate that HOXB13 is essential to the proliferation of both AR-positive and -negative PCa. Strikingly, HOXB13 is remarkably selective and has almost no effect on non-prostatic tissues. Despite this common essentiality in PCa, HOXB13 activity is markedly different in AR-negative PCa, where interactions with the AP-1 change the HOXB13 cistrome in stem-cell like castration-resistant prostate cancer. We show that HOXB13 activity is commonly mediated by SMARCD2, a member of the mSWI/SNF chromatin remodeling complex. Despite the distinct transcription factor interactions in AR-positive and -negative PCa the HOXB13/SMARCD2 commonly alters chromatin accessibility at HOXB13 binding sites that causes increased proliferation in PCa. Overall, this work demonstrates a novel mechanism of action for HOXB13 and highlights its critical role in AR-negative castration-resistant prostate cancer.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity 96%
- AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer 96%
- Disassembly of hemidesmosomes promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin into focal adhesions 95%
Similar papers in this journal
- DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis 96%
- The CIC-ERF co-deletion underlies fusion independent activation of ETS family member, ETV1, to drive prostate cancer progression 96%
- GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis 96%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.